The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: A Pilot Pre-operative Window Trial of Black Cohosh in Women With Ductal Carcinoma in Situ
Official Title: A Pilot Pre-operative Window Trial of Black Cohosh in Women With Ductal Carcinoma in Situ
Study ID: NCT01628536
Brief Summary: The investigators hypothesize that black cohosh, as a potentially therapeutic agent, will reduce the overall size and aggressiveness of ductal carcinoma in situ (DCIS) when given in a pre-operative setting.
Detailed Description: The overarching hypothesis of our research is that black cohosh has potential to be a well-tolerated, effective agent for the treatment of early breast cancer. This pilot study represents a first step in exploring this hypothesis by demonstrating preliminary evidence of specific anti-tumor effect of black cohosh on areas of ductal carcinoma in situ (DCIS) in the breast.
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Erin Hofstatter, MD, New Haven, Connecticut, United States
Name: Erin Hofstatter, MD
Affiliation: Yale University
Role: PRINCIPAL_INVESTIGATOR